Cargando…
Past and Future Strategies to Inhibit Membrane Localization of the KRAS Oncogene
KRAS is one of the most studied oncogenes. It is well known that KRAS undergoes post-translational modifications at its C-terminal end. These modifications are essential for its membrane location and activity. Despite significant efforts made in the past three decades to target the mechanisms involv...
Autores principales: | Haidar, Malak, Jacquemin, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707736/ https://www.ncbi.nlm.nih.gov/pubmed/34947990 http://dx.doi.org/10.3390/ijms222413193 |
Ejemplares similares
-
Targeting Oncogenic BRAF: Past, Present, and Future
por: Zaman, Aubhishek, et al.
Publicado: (2019) -
Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function
por: Kattan, Walaa E, et al.
Publicado: (2019) -
Oncogenic KRAS: Signaling and Drug Resistance
por: Kim, Hyeon Jin, et al.
Publicado: (2021) -
Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
por: Uras, Iris Z., et al.
Publicado: (2020) -
Targeting the undruggable oncogenic KRAS: the dawn of hope
por: Asimgil, Hande, et al.
Publicado: (2022)